go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Connecticut rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $933,254 · 10th–90th $0$1,584,8930%20%40%10th90th$933,254Professionalmedian $562,341 · 10th–90th $562,341$676,0830%50%90th$562,341$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$776,247.12
Median
$977,237.22
Typical High
$1,698,243.65
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$616,595.00
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.03
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
Cigna
Setting
Professional
Modifier
Global
Typical Low
$537,031.80
Median
$562,341.33
Typical High
$676,082.98
ConnectiCare
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$912,010.84
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$575,439.94
Typical High
$954,992.59